255 related articles for article (PubMed ID: 21490444)
1. Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.
Sangoi AR; Fujiwara M; West RB; Montgomery KD; Bonventre JV; Higgins JP; Rouse RV; Gokden N; McKenney JK
Am J Surg Pathol; 2011 May; 35(5):678-86. PubMed ID: 21490444
[TBL] [Abstract][Full Text] [Related]
2. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
3. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker.
Gokden N; Gokden M; Phan DC; McKenney JK
Am J Surg Pathol; 2008 Oct; 32(10):1462-7. PubMed ID: 18685487
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor.
Li H; Hes O; MacLennan GT; Eastwood DC; Iczkowski KA
Virchows Arch; 2015 May; 466(5):581-8. PubMed ID: 25690138
[TBL] [Abstract][Full Text] [Related]
5. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma.
Lin F; Zhang PL; Yang XJ; Shi J; Blasick T; Han WK; Wang HL; Shen SS; Teh BT; Bonventre JV
Am J Surg Pathol; 2007 Mar; 31(3):371-81. PubMed ID: 17325478
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distinction of renal cell carcinoma from other carcinomas with clear-cell histomorphology: utility of CD10 and CA-125 in addition to PAX-2, PAX-8, RCCma, and adipophilin.
Mentrikoski MJ; Wendroth SM; Wick MR
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):635-41. PubMed ID: 25279712
[TBL] [Abstract][Full Text] [Related]
7. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
8. The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.
Sangoi AR; Karamchandani J; Kim J; Pai RK; McKenney JK
Adv Anat Pathol; 2010 Nov; 17(6):377-93. PubMed ID: 20966644
[TBL] [Abstract][Full Text] [Related]
9. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration.
Yang B; Ali SZ; Rosenthal DL
Diagn Cytopathol; 2002 Sep; 27(3):149-52. PubMed ID: 12203861
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers.
Lapinski JE; Chen L; Zhou M
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):414-21. PubMed ID: 20861762
[TBL] [Abstract][Full Text] [Related]
11. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
[TBL] [Abstract][Full Text] [Related]
12. Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma.
Rivera AL; Takei H; Zhai J; Shen SS; Ro JY; Powell SZ
Neuropathology; 2010 Dec; 30(6):580-5. PubMed ID: 20374497
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of putative renal cell carcinoma markers PAX-2, PAX-8, and hKIM-1 in germ cell tumors: a tissue microarray study of 100 cases.
Sangoi AR; McKenney JK; Brooks JD; Bonventre JV; Higgins JP
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):451-3. PubMed ID: 22495365
[TBL] [Abstract][Full Text] [Related]
16. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.
Smith NE; Illei PB; Allaf M; Gonzalez N; Morris K; Hicks J; Demarzo A; Reuter VE; Amin MB; Epstein JI; Netto GJ; Argani P
Am J Surg Pathol; 2014 May; 38(5):604-14. PubMed ID: 24618616
[TBL] [Abstract][Full Text] [Related]
17. The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms.
Enriquez ML; Lal P; Ziober A; Wang L; Tomaszewski JE; Bing Z
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):141-5. PubMed ID: 22553814
[TBL] [Abstract][Full Text] [Related]
18. The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray.
He H; Zhou GX; Zhou M; Chen L
Int J Gynecol Pathol; 2011 Sep; 30(5):425-30. PubMed ID: 21804394
[TBL] [Abstract][Full Text] [Related]
19. PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.
Ozcan A; Zhai Q; Javed R; Shen SS; Coffey D; Krishnan B; Truong LD
Arch Pathol Lab Med; 2010 Aug; 134(8):1121-9. PubMed ID: 20670131
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
